Clinical trial
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on…
NCT00203580 · University of Calgary, Other · Completed
Key facts
| NCT number | NCT00203580 |
|---|---|
| Title | Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) |
| Official title | A Randomized Trial of the Effect of Low-Molecular-Weight Heparin Versus Warfarin Sodium on the Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (Main LITE Study) |
| Lead sponsor | University of Calgary, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) LEO Pharma Industry Dupont Applied Biosciences |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Thrombosis, Thromboembolism, Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Tinzaparin sodium |
| Enrollment | 910 |
| Start date | Dec 1, 1994 |
| Completion | Mar 1, 2002 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 9, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: